Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GERN |
---|---|---|
09:32 ET | 2906993 | 4.525 |
09:34 ET | 947475 | 4.56 |
09:36 ET | 1224296 | 4.6499 |
09:38 ET | 1184534 | 4.82 |
09:39 ET | 1415192 | 4.8931 |
09:41 ET | 2839532 | 5.1001 |
09:43 ET | 2087960 | 4.97 |
09:45 ET | 1407065 | 4.9999 |
09:48 ET | 1380631 | 4.8885 |
09:50 ET | 2181608 | 4.975 |
09:52 ET | 667136 | 4.9106 |
09:54 ET | 1196462 | 4.84 |
09:56 ET | 1270029 | 4.89 |
09:57 ET | 780561 | 4.8599 |
09:59 ET | 660571 | 4.89 |
10:01 ET | 810517 | 4.8788 |
10:03 ET | 376318 | 4.865 |
10:06 ET | 1061393 | 4.96 |
10:08 ET | 491110 | 4.885 |
10:10 ET | 1184996 | 4.7299 |
10:12 ET | 543060 | 4.715 |
10:14 ET | 453546 | 4.665 |
10:15 ET | 291241 | 4.6899 |
10:17 ET | 360391 | 4.71 |
10:19 ET | 199189 | 4.74 |
10:21 ET | 309358 | 4.73 |
10:24 ET | 379301 | 4.6912 |
10:26 ET | 232212 | 4.725 |
10:28 ET | 302172 | 4.6701 |
10:30 ET | 575748 | 4.645 |
10:32 ET | 301530 | 4.6412 |
10:33 ET | 1152775 | 4.535 |
10:35 ET | 962094 | 4.4946 |
10:37 ET | 747469 | 4.605 |
10:39 ET | 805878 | 4.5488 |
10:42 ET | 297964 | 4.615 |
10:44 ET | 622032 | 4.6715 |
10:46 ET | 833084 | 4.7149 |
10:48 ET | 804582 | 4.7088 |
10:50 ET | 397061 | 4.6212 |
10:51 ET | 388160 | 4.675 |
10:53 ET | 308939 | 4.7 |
10:55 ET | 219906 | 4.695 |
10:57 ET | 352688 | 4.595 |
11:00 ET | 162195 | 4.575 |
11:02 ET | 172086 | 4.5913 |
11:04 ET | 268542 | 4.62 |
11:06 ET | 584746 | 4.65 |
11:08 ET | 723891 | 4.54 |
11:09 ET | 346378 | 4.545 |
11:11 ET | 163465 | 4.585 |
11:13 ET | 111540 | 4.6 |
11:15 ET | 254793 | 4.655 |
11:18 ET | 215529 | 4.67 |
11:20 ET | 225688 | 4.665 |
11:22 ET | 248102 | 4.665 |
11:24 ET | 363295 | 4.685 |
11:26 ET | 388955 | 4.685 |
11:27 ET | 144954 | 4.665 |
11:29 ET | 277623 | 4.655 |
11:31 ET | 331854 | 4.595 |
11:33 ET | 289409 | 4.65 |
11:36 ET | 178062 | 4.655 |
11:38 ET | 70543 | 4.655 |
11:40 ET | 324378 | 4.6601 |
11:42 ET | 915531 | 4.82 |
11:44 ET | 1058216 | 4.765 |
11:45 ET | 726992 | 4.675 |
11:47 ET | 236790 | 4.685 |
11:49 ET | 341047 | 4.675 |
11:51 ET | 246459 | 4.735 |
11:54 ET | 166271 | 4.72 |
11:56 ET | 141543 | 4.7012 |
11:58 ET | 200156 | 4.765 |
12:00 ET | 98458 | 4.72 |
12:02 ET | 156916 | 4.72 |
12:03 ET | 246474 | 4.72 |
12:05 ET | 341123 | 4.735 |
12:07 ET | 512900 | 4.7 |
12:09 ET | 340813 | 4.695 |
12:12 ET | 179192 | 4.6699 |
12:14 ET | 219920 | 4.61 |
12:16 ET | 190098 | 4.66 |
12:18 ET | 202917 | 4.64 |
12:20 ET | 153780 | 4.68 |
12:21 ET | 176061 | 4.705 |
12:23 ET | 135455 | 4.7 |
12:25 ET | 179866 | 4.715 |
12:27 ET | 184280 | 4.705 |
12:30 ET | 98703 | 4.7 |
12:32 ET | 481798 | 4.69 |
12:34 ET | 147216 | 4.725 |
12:36 ET | 457409 | 4.7 |
12:38 ET | 361315 | 4.6492 |
12:39 ET | 131175 | 4.695 |
12:41 ET | 159757 | 4.695 |
12:43 ET | 111612 | 4.685 |
12:45 ET | 163393 | 4.7 |
12:48 ET | 174894 | 4.695 |
12:50 ET | 195558 | 4.6997 |
12:52 ET | 277187 | 4.685 |
12:54 ET | 241551 | 4.675 |
12:56 ET | 165416 | 4.685 |
12:57 ET | 107600 | 4.695 |
12:59 ET | 241252 | 4.695 |
01:01 ET | 98340 | 4.69 |
01:03 ET | 142337 | 4.695 |
01:06 ET | 141057 | 4.68 |
01:08 ET | 59964 | 4.695 |
01:10 ET | 186150 | 4.687 |
01:12 ET | 77451 | 4.685 |
01:14 ET | 207005 | 4.695 |
01:15 ET | 104833 | 4.67 |
01:17 ET | 55849 | 4.6788 |
01:19 ET | 193017 | 4.695 |
01:21 ET | 66312 | 4.7 |
01:24 ET | 191616 | 4.685 |
01:26 ET | 39687 | 4.685 |
01:28 ET | 297737 | 4.695 |
01:30 ET | 79402 | 4.685 |
01:32 ET | 119687 | 4.695 |
01:33 ET | 71220 | 4.69 |
01:35 ET | 225691 | 4.685 |
01:37 ET | 280572 | 4.675 |
01:39 ET | 350103 | 4.675 |
01:42 ET | 61759 | 4.675 |
01:44 ET | 124275 | 4.7093 |
01:46 ET | 160693 | 4.715 |
01:48 ET | 112570 | 4.69 |
01:50 ET | 62315 | 4.6933 |
01:51 ET | 132888 | 4.682 |
01:53 ET | 85591 | 4.685 |
01:55 ET | 98248 | 4.685 |
01:57 ET | 60481 | 4.685 |
02:00 ET | 130973 | 4.655 |
02:02 ET | 215243 | 4.615 |
02:04 ET | 133900 | 4.635 |
02:06 ET | 108631 | 4.615 |
02:08 ET | 197324 | 4.605 |
02:09 ET | 204380 | 4.575 |
02:11 ET | 223714 | 4.575 |
02:13 ET | 196905 | 4.585 |
02:15 ET | 248055 | 4.575 |
02:18 ET | 142413 | 4.615 |
02:20 ET | 186116 | 4.605 |
02:22 ET | 166370 | 4.625 |
02:24 ET | 135969 | 4.635 |
02:26 ET | 147144 | 4.64 |
02:27 ET | 233226 | 4.615 |
02:29 ET | 98850 | 4.6202 |
02:31 ET | 200562 | 4.635 |
02:33 ET | 59215 | 4.635 |
02:36 ET | 143819 | 4.635 |
02:38 ET | 244522 | 4.665 |
02:40 ET | 256796 | 4.645 |
02:42 ET | 90051 | 4.635 |
02:44 ET | 146501 | 4.635 |
02:45 ET | 170426 | 4.615 |
02:47 ET | 469717 | 4.62 |
02:49 ET | 97842 | 4.625 |
02:51 ET | 332746 | 4.635 |
02:54 ET | 91685 | 4.635 |
02:56 ET | 154295 | 4.65 |
02:58 ET | 542693 | 4.675 |
03:00 ET | 119807 | 4.6699 |
03:02 ET | 412700 | 4.7499 |
03:03 ET | 418977 | 4.755 |
03:05 ET | 273462 | 4.765 |
03:07 ET | 703853 | 4.665 |
03:09 ET | 328950 | 4.655 |
03:12 ET | 192702 | 4.65 |
03:14 ET | 100152 | 4.6698 |
03:16 ET | 595849 | 4.665 |
03:18 ET | 152550 | 4.6583 |
03:20 ET | 368721 | 4.645 |
03:21 ET | 256076 | 4.615 |
03:23 ET | 49137 | 4.615 |
03:25 ET | 264716 | 4.615 |
03:27 ET | 76298 | 4.625 |
03:30 ET | 172172 | 4.595 |
03:32 ET | 257940 | 4.6 |
03:34 ET | 166827 | 4.58 |
03:36 ET | 248790 | 4.565 |
03:38 ET | 172673 | 4.564 |
03:39 ET | 543790 | 4.575 |
03:41 ET | 281628 | 4.565 |
03:43 ET | 372707 | 4.535 |
03:45 ET | 420666 | 4.535 |
03:48 ET | 303862 | 4.53 |
03:50 ET | 561546 | 4.515 |
03:52 ET | 593865 | 4.565 |
03:54 ET | 567720 | 4.52 |
03:56 ET | 1017507 | 4.58 |
03:57 ET | 1015470 | 4.595 |
03:59 ET | 1879762 | 4.59 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Geron Corp | 2.1B | -13.3x | --- |
Vera Therapeutics Inc | 2.1B | -18.8x | --- |
CG Oncology Inc | 2.2B | -31.0x | --- |
Celldex Therapeutics Inc | 2.2B | -12.4x | --- |
Rocket Pharmaceuticals Inc | 1.9B | -7.9x | --- |
Agios Pharmaceuticals Inc | 2.1B | -7.6x | --- |
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the treatment of several myeloid hematologic malignancies, including a Phase 3 clinical trial, named IMpactMF, in relapsed/refractory myelofibrosis (MF) with overall survival as the primary endpoint, that is enrolling patients. It is also conducting a Phase 1 combination therapy clinical trial, named IMproveMF, in first-line Intermediate-1, Intermediate-2 or High-Risk myelofibrosis, or frontline MF, that is enrolling patients and imetelstat is being studied in an investigator-led Phase 2 clinical trial, named IMpress, in Intermediate-2 or High-Risk myelodysplastic syndromes and acute myeloid leukemia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
---|---|
Revenue (TTM) | $520.0K |
Shares Outstanding | 593.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.42 |
EPS | $-0.35 |
Book Value | $0.46 |
P/E Ratio | -13.3x |
Price/Sales (TTM) | 4,049.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -40,381.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.